- Home
- PHAT vs AUNA Comparison
PHAT vs AUNA Comparison
Compare PHAT & AUNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PHAT
- AUNA
- Stock Information
- Founded
- PHAT 2018
- AUNA 1989
- Country
- PHAT United States
- AUNA Luxembourg
- Employees
- PHAT N/A
- AUNA N/A
- Industry
- PHAT Biotechnology: Pharmaceutical Preparations
- AUNA
- Sector
- PHAT Health Care
- AUNA
- Exchange
- PHAT Nasdaq
- AUNA NYSE
- Market Cap
- PHAT 465.0M
- AUNA 521.9M
- IPO Year
- PHAT 2019
- AUNA 2024
- Fundamental
- Price
- PHAT $6.96
- AUNA $8.42
- Analyst Decision
- PHAT Strong Buy
- AUNA Strong Buy
- Analyst Count
- PHAT 4
- AUNA 4
- Target Price
- PHAT $23.00
- AUNA $13.40
- AVG Volume (30 Days)
- PHAT 971.9K
- AUNA 64.6K
- Earning Date
- PHAT 03-06-2025
- AUNA 11-19-2024
- Dividend Yield
- PHAT N/A
- AUNA N/A
- EPS Growth
- PHAT N/A
- AUNA N/A
- EPS
- PHAT N/A
- AUNA N/A
- Revenue
- PHAT $26,270,000.00
- AUNA $1,168,151,825.00
- Revenue This Year
- PHAT $7,622.43
- AUNA $17.06
- Revenue Next Year
- PHAT $236.87
- AUNA $9.63
- P/E Ratio
- PHAT N/A
- AUNA N/A
- Revenue Growth
- PHAT N/A
- AUNA 18.72
- 52 Week Low
- PHAT $6.07
- AUNA $6.17
- 52 Week High
- PHAT $19.71
- AUNA $10.85
- Technical
- Relative Strength Index (RSI)
- PHAT 37.02
- AUNA N/A
- Support Level
- PHAT $6.36
- AUNA N/A
- Resistance Level
- PHAT $7.20
- AUNA N/A
- Average True Range (ATR)
- PHAT 0.48
- AUNA 0.00
- MACD
- PHAT 0.08
- AUNA 0.00
- Stochastic Oscillator
- PHAT 30.48
- AUNA 0.00
About PHAT Phathom Pharmaceuticals Inc.
Phathom Pharmaceuticals Inc operates as a clinical-stage biopharmaceutical company. The firm is focused on developing and commercializing novel treatments for gastrointestinal, or GI, diseases. Its product comprises vonoprazan, an oral small-molecule potassium competitive acid blocker medicine that blocks acid secretion in the stomach. Vonoprazan shows rapid, potent, and durable anti-secretory effects and has demonstrated clinical benefits in the treatment of gastroesophageal reflux disease, and in combination with antibiotics for the treatment of Helicobacter pylori infection.
About AUNA AUNA S A
Auna SA is a healthcare provider. It operates hospitals and clinics in Mexico, Peru, and Colombia, and provides prepaid healthcare plans in Peru, and dental and vision plans in Mexico. Its network includes several healthcare network facilities, consisting of hospitals, outpatient, prevention, and wellness facilities. The company operates in the following segments; Oncosalud Peru, Healthcare services in Peru, Healthcare services in Colombia, and Healthcare services in Mexico. Key revenue is generated from Peru.